11 – 20 of 142
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Into the twilight zone – should ER-low breast cancer be treated as triple negative breast cancer?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Model of Health-Related Quality of Life in Breast Cancer Patients Using Cross-Sectional Data: The Role of Resilience
(
- Contribution to journal › Article
-
Mark
Prediction of High Nodal Burden in Patients With Sentinel Node-Positive Luminal ERBB2-Negative Breast Cancer
(
- Contribution to journal › Article
-
Mark
Breast cancer hormone receptor levels and benefit from adjuvant tamoxifen in a randomized trial with long-term follow-up
(
- Contribution to journal › Article
-
Mark
Axillary clearance and chemotherapy rates in ER+HER2− breast cancer : secondary analysis of the SENOMAC trial
(
- Contribution to journal › Article
-
Mark
Omitting Axillary Dissection in Breast Cancer with Sentinel-Node Metastases
(
- Contribution to journal › Article
-
Mark
Completion axillary lymph node dissection for the identification of pN2–3 status as an indication for adjuvant CDK4/6 inhibitor treatment : a post-hoc analysis of the randomised, phase 3 SENOMAC trial
(
- Contribution to journal › Article
-
Mark
Hormone receptor mRNA and protein levels as predictors of premenopausal tamoxifen benefit
(
- Contribution to journal › Article
-
Mark
Timing and type of breast reconstruction in SweBRO 3 : long-term outcomes
(
- Contribution to journal › Article
-
Mark
The complexity of needs and roles of family members during breast cancer rehabilitation : a qualitative study
(
- Contribution to journal › Article